# Aizon

生产面向制药生产的AI驱动生产智能平台，将分析功能与合规功能相结合，并有记录的战略合作（Sequence）将AI驱动解决方案扩展至生物制药生产领域。

Source: https://cn.bioecon.ru/companies/aizon/
Updated: 2026-08-19

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 共4轮融资，累计$4410万 | https://startupintros.com/orgs/aizon |
| 营收 | 估计每年介于 $12.6M 至 $25.1M [中等置信度] | https://getlatka.com/companies/aizon, https://healthydata.science/listings/aizon-how-top-pharma-leaders-are-using-ai-to-slash-time-to-market-by-30/ |
| 员工人数 | 员工131至159人 | https://getlatka.com/companies/aizon |
| 认证 | ISO 9001、ISO 27001、ISO 27017及SOC 2认证 | https://healthydata.science/listings/aizon-how-top-pharma-leaders-are-using-ai-to-slash-time-to-market-by-30/, https://www.aizon.ai/trust-center |
| 监管批准 | 该平台支持符合FDA 21 CFR Part 11和欧盟GMP附录11要求，按照GAMP 5原则设计 | https://www.aizon.ai/2025/for-llms, https://www.aizon.ai/trust-center |
| 生产基地 | 美国旧金山和西班牙巴塞罗那 | https://startupintros.com/orgs/aizon, https://www.aizon.ai/2025/for-llms |
| 产能 | 平台可扩展，每年可支持数十到1,000+批次 [中等置信度] | https://connect.aizon.ai/hubfs/Aizon-GxP-AI-Pharma-Manufacturing-Data-Sheet.pdf, https://healthydata.science/listings/aizon-how-top-pharma-leaders-are-using-ai-to-slash-time-to-market-by-30/ |

独立来源: getlatka.com, healthydata.science, startupintros.com

## 技术

- [AI生物工艺优化SaaS](https://cn.bioecon.ru/technology/ai-bioprocess-optimization-as-saas/)